Page last updated: 2024-10-22

albendazole and Bile Duct Neoplasms

albendazole has been researched along with Bile Duct Neoplasms in 1 studies

Bile Duct Neoplasms: Tumors or cancer of the BILE DUCTS.

Research Excerpts

ExcerptRelevanceReference
"Albendazole (ABZ) is a broad-spectrum anti-parasitic drug that exhibits antitumor effects against several carcinomas."5.72Albendazole-induced autophagy blockade contributes to elevated apoptosis in cholangiocarcinoma cells through AMPK/mTOR activation. ( He, Q; Li, X; Pan, X; Wu, Y; Yin, Y, 2022)
"Albendazole (ABZ) is a broad-spectrum anti-parasitic drug that exhibits antitumor effects against several carcinomas."1.72Albendazole-induced autophagy blockade contributes to elevated apoptosis in cholangiocarcinoma cells through AMPK/mTOR activation. ( He, Q; Li, X; Pan, X; Wu, Y; Yin, Y, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
He, Q1
Yin, Y1
Pan, X1
Wu, Y1
Li, X1

Other Studies

1 other study available for albendazole and Bile Duct Neoplasms

ArticleYear
Albendazole-induced autophagy blockade contributes to elevated apoptosis in cholangiocarcinoma cells through AMPK/mTOR activation.
    Toxicology and applied pharmacology, 2022, 11-01, Volume: 454

    Topics: Albendazole; AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Bile Duct Neoplasms; Bile

2022